Stay updated on Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior government funding operating-status notice (and Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:26:22.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    New site-wide notice about government funding and NIH Clinical Center status appears, and the page revision is updated to v3.4.1; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:41:56.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Show glossary toggle was added and a revision indicator (Revision: v3.4.0) appears on the page. QC-related labels and policy wording were updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data').
    Difference
    0.1%
    Check dated 2026-01-28T06:19:16.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing Revision: v3.3.3. This update appears to be a metadata/version tag and does not modify core study content.
    Difference
    0.0%
    Check dated 2026-01-14T02:32:36.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Added a Locations section listing multiple U.S. states as study sites and updated the revision to v3.3.3; the prior v3.3.2 location listings and the HHS disclosure item were removed.
    Difference
    2%
    Check dated 2025-12-23T17:21:19.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added to the study documents, replacing the previous Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T20:53:17.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.